NO750295L - - Google Patents

Info

Publication number
NO750295L
NO750295L NO750295A NO750295A NO750295L NO 750295 L NO750295 L NO 750295L NO 750295 A NO750295 A NO 750295A NO 750295 A NO750295 A NO 750295A NO 750295 L NO750295 L NO 750295L
Authority
NO
Norway
Prior art keywords
virus
strain
atcc
influenza type
influenza
Prior art date
Application number
NO750295A
Other languages
English (en)
Norwegian (no)
Inventor
J Peetermans
M Lobmann
J-M Prevost
E Vascoboinic
Original Assignee
Rit Rech Ind Therapeut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rit Rech Ind Therapeut filed Critical Rit Rech Ind Therapeut
Publication of NO750295L publication Critical patent/NO750295L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO750295A 1974-02-04 1975-01-30 NO750295L (enrdf_load_html_response)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43917674A 1974-02-04 1974-02-04

Publications (1)

Publication Number Publication Date
NO750295L true NO750295L (enrdf_load_html_response) 1975-09-01

Family

ID=23743623

Family Applications (1)

Application Number Title Priority Date Filing Date
NO750295A NO750295L (enrdf_load_html_response) 1974-02-04 1975-01-30

Country Status (21)

Country Link
JP (1) JPS50107122A (enrdf_load_html_response)
AT (1) AT338416B (enrdf_load_html_response)
BE (1) BE824970A (enrdf_load_html_response)
CA (1) CA1047922A (enrdf_load_html_response)
CH (1) CH596316A5 (enrdf_load_html_response)
CS (1) CS202545B2 (enrdf_load_html_response)
DD (1) DD116474A5 (enrdf_load_html_response)
DE (1) DE2504373A1 (enrdf_load_html_response)
DK (1) DK141926B (enrdf_load_html_response)
ES (1) ES434384A1 (enrdf_load_html_response)
FI (1) FI750260A7 (enrdf_load_html_response)
FR (1) FR2259616B1 (enrdf_load_html_response)
GB (1) GB1439742A (enrdf_load_html_response)
HU (1) HU170522B (enrdf_load_html_response)
IE (1) IE42043B1 (enrdf_load_html_response)
IL (1) IL46446A (enrdf_load_html_response)
LU (1) LU71784A1 (enrdf_load_html_response)
NL (1) NL7501028A (enrdf_load_html_response)
NO (1) NO750295L (enrdf_load_html_response)
SE (1) SE424503B (enrdf_load_html_response)
ZA (1) ZA75248B (enrdf_load_html_response)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2588918A (en) * 1947-11-07 1952-03-11 William T Graham Mechanism for raising and lowering plow frames relative to the ground wheels
JPS6042209B2 (ja) * 1974-05-31 1985-09-20 北里研究所（社団法人） インフルエンザウイルスの新鮮分離株を発育鶏卵へ短期間で順化させる方法

Also Published As

Publication number Publication date
SE424503B (sv) 1982-07-26
ATA76675A (de) 1976-12-15
LU71784A1 (enrdf_load_html_response) 1975-06-24
DK9775A (enrdf_load_html_response) 1975-09-29
HU170522B (enrdf_load_html_response) 1977-06-28
NL7501028A (nl) 1975-08-06
CA1047922A (en) 1979-02-06
DD116474A5 (enrdf_load_html_response) 1975-11-20
CH596316A5 (enrdf_load_html_response) 1978-03-15
FR2259616B1 (enrdf_load_html_response) 1980-01-04
FR2259616A1 (enrdf_load_html_response) 1975-08-29
CS202545B2 (en) 1981-01-30
GB1439742A (en) 1976-06-16
ES434384A1 (es) 1976-12-01
ZA75248B (en) 1976-01-28
AT338416B (de) 1977-08-25
IE42043B1 (en) 1980-05-21
DE2504373A1 (de) 1975-08-07
JPS50107122A (enrdf_load_html_response) 1975-08-23
BE824970A (fr) 1975-07-30
DK141926B (da) 1980-07-21
SE7500549L (enrdf_load_html_response) 1975-08-05
FI750260A7 (enrdf_load_html_response) 1975-08-05
AU7734675A (en) 1976-07-15
DK141926C (enrdf_load_html_response) 1981-01-19
IL46446A (en) 1978-01-31
IL46446A0 (en) 1975-04-25
IE42043L (en) 1975-08-04

Similar Documents

Publication Publication Date Title
Saito et al. Characterization of a human H9N2 influenza virus isolated in Hong Kong
Tumpey et al. Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection
AU770923B2 (en) Inactivated influenza virus vaccine for nasal or oral administration
Takada et al. Avirulent avian influenza virus as a vaccine strain against a potential human pandemic
Ruben et al. A new subunit influenza vaccine: acceptability compared with standard vaccines and effect of dose on antigenicity
Kendal Cold-adapted live attenuated influenza vaccines developed in Russia: can they contribute to meeting the needs for influenza control in other countries?
PERKINS et al. Evidence for protective effect of an inactivated rhinovirus vaccine administered by the nasal route
US4552758A (en) Human use of avian-human reassortants as vaccines for influenza A virus
US4009258A (en) Influenza vaccine containing a recombinant, antigenically hybridized virus and method of using the same
US4338296A (en) Influenza virus and process of producing a vaccine therefrom
Tamura et al. Escherichia coli heat-labile enterotoxin B subunits supplemented with a trace amount of the holotoxin as an adjuvant for nasal influenza vaccine
US5162112A (en) Influenza vaccine
US4318903A (en) Live influenza virus vaccine and the preparation thereof
Gorse et al. Superiority of live attenuated compared with inactivated influenza A virus vaccines in older, chronically III adults
Kilbourne et al. Influenza vaccines: Summary of influenza workshop V
Mostow et al. Studies on inactivated influenza vaccines: II. Effect of increasing dosage on antibody response and adverse reactions in man
WO1992000097A1 (en) Method of using cold-adapted live influenza virus vaccine as an antiviral agent against influenza
US3953592A (en) Live influenza virus vaccines and preparation thereof
US20130315951A1 (en) Compositions and methods for stimulating an immune response against infectious agents
US3961046A (en) Mumps vaccine and preparation thereof
Butterworth et al. Replication of rhinoviruses
Rimmelzwaan et al. Influenza virus subtype cross-reactivities of haemagglutination inhibiting and virus neutralising serum antibodies induced by infection or vaccination with an ISCOM-based vaccine
US3962423A (en) Live influenza type B virus vaccines and preparation thereof
Romanova et al. Interference between cold-adapted (ca) influenza A and B vaccine reassortants or between ca reassortants and wild-type strains in eggs and mice
NO750295L (enrdf_load_html_response)